MedPath

Open Versus Robotic Retromuscular Ventral Hernia Repair

Not Applicable
Completed
Conditions
Ventral Hernia
Registration Number
NCT03007758
Lead Sponsor
Prisma Health-Upstate
Brief Summary

The purpose of this study is to determine how the robotic retromuscular hernia repair compares to the open retromuscular hernia repair for large hernia defects in patients at higher risk of wound complications.

Detailed Description

All patients presenting to the Greenville Health System Hernia Center who meet the inclusion criteria will be considered for enrollment. Patients who qualify and agree to participate will be randomized 1:1 to robotic retromuscular ventral hernia repair or open retromuscular ventral hernia repair. Data to be collected includes the following: demographic information, medical characteristics, medications, medical and surgical history, operative details, hospital stay data, and patient-reported outcomes via a quality of life questionnaire. Post-operative follow-up will occur at 2 weeks, 6 weeks, 6 months, 1 year and 2 years.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
101
Inclusion Criteria
  • Ventral or incisional hernia measuring ≥ 7 cm and ≤ 15 cm.
  • At least one of the following risk factors: Body Mass Index > 30, Chronic Obstructive Pulmonary Disease, Diabetes Mellitus, current smoker (within 1 month)
Exclusion Criteria
  • Current abdominal wall infection
  • Presence of ileostomy, colostomy, or ileal conduit
  • Center for Disease Control wound class 3 or 4
  • Hernia defect < 7 cm or >15 cm
  • Pregnant women

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Composite Outcome of Diagnosis of Surgical Site Occurrence or Infection, Hospital Readmission, or Hernia RecurrenceThrough study completion, an average of 2 years

A composite outcome of events which are clinically significant including but not limited to seroma requiring procedural intervention, skin dehiscence, cellulitis, hematoma, skin necrosis, and surgical site infections which may require interventions such as wound care or antibiotic therapy.

Secondary Outcome Measures
NameTimeMethod
All Surgical Site OccurrencesPost-operatively: 2 weeks, 6 weeks, 6 months, 1 year, 2 years

Surgical site occurrence (SSO) is defined as all wound complications that occur after a surgical procedure but are not surgical site infections.

Surgical Site Occurrences Requiring Procedural InterventionPost-operatively: 2 weeks, 6 weeks, 6 months, 1 year, 2 years

Surgical site occurrence (SSO) is defined as all wound complications that occur after a surgical procedure but are not surgical site infections

All Surgical Site InfectionsPost-operatively: 2 weeks, 6 weeks, 6 months, 1 year, 2 years

Surgical site occurrence is defined as all wound complications that occur after a surgical procedure but are not surgical site infections.

Surgical Site Infections Requiring Procedural InterventionPost-operatively: 2 weeks, 6 weeks, 6 months, 1 year, 2 years
Length of Stay at Hospital Measured in DaysTime from procedure until discharge, an expected range of 2 to10 days
Operative Time (Procedure Start to Procedure Finish Measured in Minutes)Day of surgery
Cost for Hospital Charges From Billing OfficeThrough study completion, an average of 2 years
BMIMeasured at study enrollment

Body Mass Index

Hernia Widthmeasured at surgery

Width of Hernia

Hernia Lengthmeasured at surgery

Length of Hernia

Quality of Life Via Questionnaire - 30 Daysassessed at Baseline and Post-operatively at 30 days

Patient reported outcomes via the Hernia related quality of life score. The survey contains 12 statements about the patients abdominal wall and asks the patient to rate how strongly the disagree (1) or agree (6) with the statements on a scale 1-6. The score is calculated with the following formula: (120-\[(20/12)\*(sum of response on all 12 questions)\]).The highest possible number, meaning the abdominal wall does not affect the patient, is 100, and the lowest, meaning the abdominal wall greatly affects the patient's quality of life, is a 0.

Quality of Life Via Questionnaire - 6 Through 12 Monthsassessed at Baseline and Post-operatively at 6 through 12 months. Data for the 6 and 12-month patient reported outcomes were combined for analysis.

Patient reported outcomes via the Hernia related quality of life score. The survey contains 12 statements about the patients abdominal wall and asks the patient to rate how strongly the disagree (1) or agree (6) with the statements on a scale 1-6.The score is calculated with the following formula: (120-\[(20/12)\*(sum of response on all 12 questions)\]).The highest possible number, meaning the abdominal wall does not affect the patient, is 100, and the lowest, meaning the abdominal wall greatly affects the patient's quality of life, is a 0.

Quality of Life Via Questionnaire - 24 Monthsassessed at Baseline and Post-operatively at 24 months

Patient reported outcomes via the Hernia related quality of life score. The survey contains 12 statements about the patients abdominal wall and asks the patient to rate how strongly the disagree (1) or agree (6) with the statements on a scale 1-6. The score is calculated with the following formula: (120-\[(20/12)\*(sum of responses on all 12 questions)\]).The highest possible number, meaning the abdominal wall does not affect the patient, is 100, and the lowest, meaning the abdominal wall greatly affects the patient's quality of life, is a 0.

Pain Score - 30 Day Patient Reported Outcomesassessed at Baseline and Post-operatively at 30 days.

Patient is asked 3 different questions all in relation to their pain in the past 7 days: how intense was it as its worst, on average, and right now. They then rank their pain for each question on a scale of 1 - 5. 1 meaning no pain and 5 very severe pain. The pain scores were then averaged and used for this analysis.

Ventral Hernia Recurrence Inventory 1 Yearassessed at Baseline and Post-operatively at 12 months.

Patients are asked 3 yes or no questions about their hernia operation: do you feel your hernia has come back, do you feel or see a bulge, and do you have physical pain or symptoms at the site.

Ventral Hernia Recurrence Inventory 2 Yearsassessed at Baseline and Post-operatively at 24 months

Patients are asked 3 yes or no questions about their hernia operation: do you feel your hernia has come back, do you feel or see a bulge, and do you have physical pain or symptoms at the site.

Hernia Recurrenceassessed Post-operatively as 24 months

The ventral hernia recurrence inventory asked patients if they have had any additional surgery since the hernia operation. If they answer yes, they choose if the surgery was for a hernia or another reason. The answers from 1 year follow up and 2 year follow up to the last question were combined for this analysis. Composite recurrence was then determined by excluding patients with negative CT scan or physical exam but had answered the ventral hernia recurrence inventory indication the hernia recurrence.

Conversion to OpenAssessed at index surgery.

Robotic surgeries converted to open surgeries.

Pain Score - 6 or 12 Month Patient Reported Outcomesassessed at Baseline and Post-operatively at 6-12 months; data for 6 and 12-month pain scores were combined for analysis.

Patient is asked 3 different questions all in relation to their pain in the past 7 days: how intense was it as its worst, on average, and right now. They then rank their pain for each question on a scale of 1 - 5. 1 meaning no pain and 5 very severe pain. The pain scores were then averaged and used for this analysis.

Pain Score - 24 Month Patient Reported Outcomesassessed at Baseline and Post-operatively at 24 months

Patient is asked 3 different questions all in relation to their pain in the past 7 days: how intense was it as its worst, on average, and right now. They then rank their pain for each question on a scale of 1 - 5. 1 meaning no pain and 5 very severe pain. The pain scores were then averaged and used for this analysis.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.